Publications

Bob Farese, MDHaas JT, Miao J, Chanda D, Wang Y, Zhao E, Haas ME, Hirschey M, Vaitheesvaran B, Farese RV, Kurland IJ, Graham M, Crooke R, Foufelle F, Biddinger SB. Hepatic Insulin Signaling Is Required for Obesity-Dependent Expression of SREBP-1c mRNA but Not for Feeding-Dependent Expression. Cell Metab. 2012 Jun 6; 15(6):873-84. View in: PubMed
Bob Farese, MDSuppression of Oxidative Stress by ß-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor. View in: PubMed
Bob Farese, MDFarese RV, Sajan MP. Atypical protein kinase C in cardiometabolic abnormalities. Curr Opin Lipidol. 2012 Jun; 23(3):175-81. View in: PubMed
Bob Farese, MDFarese RV, Sajan MP. Atypical protein kinase C in cardiometabolic abnormalities. Curr Opin Lipidol. 2012 Jun; 23(3):175-81. View in: PubMed
Bob Farese, MDDGAT1 mutation is linked to a congenital diarrheal disorder. View in: PubMed
Bob Farese, MDFarese RV, Sajan MP. Atypical protein kinase C in cardiometabolic abnormalities. Curr Opin Lipidol. 2012 Jun; 23(3):175-81. View in: PubMed
Bob Farese, MDFarese RV, Sajan MP. Atypical protein kinase C in cardiometabolic abnormalities. Curr Opin Lipidol. 2012 Jun; 23(3):175-81. View in: PubMed
Bob Farese, MDInhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. View in: PubMed
Bob Farese, MDFarese RV, Zechner R, Newgard CB, Walther TC. The Problem of Establishing Relationships between Hepatic Steatosis and Hepatic Insulin Resistance. Cell Metab. 2012 May 2; 15(5):570-3. View in: PubMed
Bob Farese, MDSajan MP, Farese RV. Insulin signalling in hepatocytes of humans with type 2 diabetes: excessive production and activity of protein kinase C-? (PKC-?) and dependent processes and reversal by PKC-? inhibitors. Diabetologia. 2012 May; 55(5):1446-57. View in: PubMed